Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash Flows from Operating Activities:
Net Loss	$ (1,803,316)	$ (2,878,713)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	370,300	421,167
Share-based compensation expense	139,604	372,181
Accretion and amortization for debt discounts and issuance costs	521,017	202,690
Loss on debt extinguishment	$ 14,000	65,869
Shares issued in exchange for services		70,000
Warrants issued in exchange for services		$ 20,752
Fair value of embedded conversion feature	$ 1,091
Changes in operating assets and liabilities:
Accounts receivable	(34,080)	$ (21,353)
Prepaid expenses and other current assets	(3,761)	(86,085)
Accounts payable	153,584	484,797
Accrued interest and other liabilities	458,863	86,860
Deferred revenue	(78,614)	(33,967)
Deposits	$ (13,005)	(2,895)
Deferred rent		(2,515)
Net Cash Used in Operating Activities	$ (274,317)	$ (1,301,212)
Cash Flows From Investing Activities:
Payment for patent and trademark applications	(1,400)
Payment of platform development costs	(89,497)	$ (491,772)
Net Cash Used in Investing Activities	(90,897)	(491,772)
Cash Flows from Financing Activities:
Proceeds from issuance of debentures	402,000	175,000
Proceeds from notes payable related parties	50,000	$ 3,809
Repayment of convertible note	$ (49,000)
Proceeds from issuance of convertible note payable		$ 152,500
Sale of common stock, net of issuance costs		658,700
Net Cash Provided by Financing Activities	$ 403,000	990,009
Net Increase (Decrease) in Cash	37,786	(802,975)
Cash, Beginning of Period	14,119	812,064
Cash, End of Period	$ 51,905	9,089
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for interest		9,603
Non-cash Investing and Financing Transactions:
Conversion of debt to common stock shares	$ 142,514	100,000
Discount related to issuance of debt with warrants and allocated fair value to beneficial conversion feature	$ 274,122	$ 110,557